PT1150703E - Terapia de esclerose multipla com chaperonina 10 e beta-interferao - Google Patents
Terapia de esclerose multipla com chaperonina 10 e beta-interferaoInfo
- Publication number
- PT1150703E PT1150703E PT00903434T PT00903434T PT1150703E PT 1150703 E PT1150703 E PT 1150703E PT 00903434 T PT00903434 T PT 00903434T PT 00903434 T PT00903434 T PT 00903434T PT 1150703 E PT1150703 E PT 1150703E
- Authority
- PT
- Portugal
- Prior art keywords
- beta
- multiple sclerosis
- chaperonine
- interference
- sclerosis therapy
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 4
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 102100024341 10 kDa heat shock protein, mitochondrial Human genes 0.000 abstract 2
- 108010059013 Chaperonin 10 Proteins 0.000 abstract 2
- 102100026720 Interferon beta Human genes 0.000 abstract 2
- 108090000467 Interferon-beta Proteins 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Developing Agents For Electrophotography (AREA)
- Surgical Instruments (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP8239A AUPP823999A0 (en) | 1999-01-20 | 1999-01-20 | A treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1150703E true PT1150703E (pt) | 2006-05-31 |
Family
ID=3812443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00903434T PT1150703E (pt) | 1999-01-20 | 2000-01-20 | Terapia de esclerose multipla com chaperonina 10 e beta-interferao |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090214473A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1150703B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP4691257B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR100694011B1 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE313332T1 (cg-RX-API-DMAC10.html) |
| AU (2) | AUPP823999A0 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2361081C (cg-RX-API-DMAC10.html) |
| DE (1) | DE60024967T2 (cg-RX-API-DMAC10.html) |
| DK (1) | DK1150703T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2255484T3 (cg-RX-API-DMAC10.html) |
| PT (1) | PT1150703E (cg-RX-API-DMAC10.html) |
| WO (1) | WO2000043033A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007517808A (ja) * | 2004-01-16 | 2007-07-05 | キュビオ リミテッド | Ｔｏｌｌ様受容体誘導性のサイトカインおよびケモカイン分泌のシャペロニン１０調節 |
| BG66458B1 (bg) * | 2005-03-21 | 2014-10-31 | Иван Иванов | Средство за конкурентно инхибиране на ендогенен гама интерферон |
| EP2463307A1 (en) | 2005-08-31 | 2012-06-13 | CBIO Limited | Modified chaperonin 10 |
| CA2626692A1 (en) * | 2005-10-20 | 2007-04-26 | Cbio Limited | Treatment of hypersensitivity |
| MX2008011167A (es) * | 2006-03-02 | 2008-11-12 | Cbio Ltd | Regulaciòn de respuestas inmunes mediante la modulaciòn de la funciòn de cèlulas presentadoras de antìgenos. |
| BG66517B1 (bg) | 2008-04-08 | 2016-02-29 | Tigo Gmbh | Супресор на ендогенния човешки гама - интерферон |
| US9359421B2 (en) | 2008-04-08 | 2016-06-07 | Tigo Gmbh | Suppressor of the endogenous interferon-gamma |
| BG1430U1 (bg) * | 2010-06-25 | 2011-04-29 | Иван ИВАНОВ | Фармацевтично средство |
| BG67190B1 (bg) | 2017-03-29 | 2020-11-16 | Tigo Gmbh | Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995015338A1 (en) * | 1993-11-30 | 1995-06-08 | The University Of Queensland | Chaperonin 10 |
| JPH10500109A (ja) * | 1994-05-10 | 1998-01-06 | イミユロジク・フアーマシユーチカル・コーポレーシヨン | 多発性硬化症のための組成物および治療方法 |
| DE19544768C1 (de) * | 1995-11-30 | 1997-07-10 | Rentschler Arzneimittel | Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose |
-
1999
- 1999-01-20 AU AUPP8239A patent/AUPP823999A0/en not_active Abandoned
-
2000
- 2000-01-20 ES ES00903434T patent/ES2255484T3/es not_active Expired - Lifetime
- 2000-01-20 PT PT00903434T patent/PT1150703E/pt unknown
- 2000-01-20 JP JP2000594486A patent/JP4691257B2/ja not_active Expired - Fee Related
- 2000-01-20 KR KR1020017009163A patent/KR100694011B1/ko not_active Expired - Fee Related
- 2000-01-20 DE DE60024967T patent/DE60024967T2/de not_active Expired - Lifetime
- 2000-01-20 EP EP00903434A patent/EP1150703B1/en not_active Expired - Lifetime
- 2000-01-20 AU AU25271/00A patent/AU771867B2/en not_active Ceased
- 2000-01-20 CA CA2361081A patent/CA2361081C/en not_active Expired - Fee Related
- 2000-01-20 AT AT00903434T patent/ATE313332T1/de not_active IP Right Cessation
- 2000-01-20 WO PCT/AU2000/000032 patent/WO2000043033A1/en not_active Ceased
- 2000-01-20 DK DK00903434T patent/DK1150703T3/da active
-
2009
- 2009-01-29 US US12/362,456 patent/US20090214473A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2361081C (en) | 2010-09-21 |
| KR20020002376A (ko) | 2002-01-09 |
| EP1150703A1 (en) | 2001-11-07 |
| DE60024967T2 (de) | 2006-08-17 |
| CA2361081A1 (en) | 2000-07-27 |
| KR100694011B1 (ko) | 2007-03-12 |
| AU2527100A (en) | 2000-08-07 |
| EP1150703A4 (en) | 2004-11-10 |
| ES2255484T3 (es) | 2006-07-01 |
| JP4691257B2 (ja) | 2011-06-01 |
| WO2000043033A1 (en) | 2000-07-27 |
| JP2002535286A (ja) | 2002-10-22 |
| US20090214473A1 (en) | 2009-08-27 |
| DE60024967D1 (en) | 2006-01-26 |
| DK1150703T3 (da) | 2006-05-29 |
| AU771867B2 (en) | 2004-04-01 |
| ATE313332T1 (de) | 2006-01-15 |
| EP1150703B1 (en) | 2005-12-21 |
| AUPP823999A0 (en) | 1999-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| ATE232396T1 (de) | Oxydiertes thymosin beta 4 | |
| HUT76258A (en) | Compositions comprising dna damaging agents and p53, and methods for uses thereof | |
| NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| ID28003A (id) | Turunan-turunan adamantana | |
| IL130931A0 (en) | Small molecules useful in the treatment of inflammatory disease | |
| MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
| PT998287E (pt) | Utilizacao de levobupivacaina | |
| NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
| ATE82127T1 (de) | N-acetylglucosamin-zubereitungen zur buccalen anwendung. | |
| RU95106680A (ru) | Бициклические ароматические соединения и содержащие их фармацевтические и косметические композиции | |
| GEP20002092B (en) | 5,6-Dihydropyrone Derivatives Pharma¬ceutical Compositions on the Base of them and Method for Treatment of Antiviral diseases | |
| BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
| GB9907571D0 (en) | Compounds | |
| EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
| ATE313332T1 (de) | Chaperonin 10 und beta-interferon therapie für multiple sklerose | |
| DE69612056D1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
| EA199700243A1 (ru) | Производное аминотетралина для лечения сердечно-сосудистых заболеваний | |
| AU2002211577A1 (en) | Protecting therapeutic compositions from host-mediated inactivation | |
| MXPA02012089A (es) | Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos. | |
| DK0669826T3 (da) | (-)-Metrifonatholdigt lægemiddel | |
| PT1313500E (pt) | Associacoes de dalfopristina/quinupristina com o cefpirome | |
| MXPA02012091A (es) | Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero. | |
| ES2181160T3 (es) | Derivados de 1,4-dihidropiridina y su utilizacion en terapia. | |
| SE9902674D0 (sv) | New composition |